White label ELPA - ClinicalTrials.eu

Study on NECVAX-NEO1 with PD-1/PD-L1 Inhibitors for Patients with Advanced Solid Tumors

Not recruiting

1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
- Necvax-Neo1
Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Moderate to Severe Hidradenitis Suppurativa

Not recruiting

3 1 1
Investigated Drugs:
- Bimekizumab
+3
Study of Tofersen for Adults with Presymptomatic Amyotrophic Lateral Sclerosis (ALS) Due to SOD1 Gene Mutation

Not recruiting

3 1
Investigated Drugs:
- Tofersen
Study on Sirolimus for Adults with Facial Skin Sarcoidosis: Evaluating Treatment for Moderate to Severe Cases

Not recruiting

2 1 1 1
Investigated Diseases:
- Cutaneous sarcoidosis
Investigated Drugs:
- Sirolimus
Study on Frexalimab for Patients with Relapsing Multiple Sclerosis

Not recruiting

2 1
Investigated Diseases:
- Multiple sclerosis
Investigated Drugs:
- Frexalimab
Study on the Effectiveness and Safety of Camlipixant for Adults with Refractory or Unexplained Chronic Cough

Not recruiting

3 1
Investigated Drugs:
- Camlipixant
Long-term Safety Study of Dasiglucagon for Children with Congenital Hyperinsulinism

Not recruiting

3 1 1
Investigated Drugs:
- Dasiglucagon
Study on the Effects of Riociguat for Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

Not recruiting

3 1 1
Investigated Drugs:
- Riociguat
Study on Repeated Corticosteroid Injections with Methylprednisolone Acetate and Sodium Chloride for Patients with Chronic Cluster Headache

Not recruiting

3 1 1
Investigated Diseases:
- Cluster headache
Investigated Drugs:
- Methylprednisolone Acetate
- Sodium Chloride
Study of Lacutamab, Gemcitabine, and Oxaliplatin for Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma

Not recruiting

2 1 1 1
Investigated Diseases:
- Peripheral T-cell lymphoma unspecified
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies